First Trust NYSE Arca Biotechnology Index Fund Rating $262.95 +3.30 (+1.27%) Closing price 04:10 PM EasternExtended Trading$262.96 +0.00 (+0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsSEC FilingsShort Interest First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.63Holdings in FBT have an aggregate rating of Moderate Buy based on 487 analyst ratings issued in the past year covering 25 companies (87.8% of the portfolio).FBT Aggregate Price Target$262.95High Prediction$262.95Average Prediction$262.95Low Prediction$262.95Holdings in FBT have an aggregate price target of $262.95 and a range of $262.95 to $262.95 covering 25 companies (87.8% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FBT Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings4.62%NTRANatera$394.75-0.2%Moderate Buy$368.69 -6.6%231.8681 of 5 starsAnalyst Forecast4.60%HALOHalozyme Therapeutics$116.82+6.6%Moderate Buy$96.50 -17.4%123.4415 of 5 starsAnalyst Forecast4.44%ILMNIllumina$271.76+0.2%Hold$225.94 -16.9%182.8939 of 5 starsTrending NewsAnalyst Upgrade4.12%CORTCorcept Therapeutics$116.23-1.3%Moderate Buy$138.17 18.9%84.0814 of 5 stars3.97%GMABGenmab A/S$36.89+0.9%Moderate Buy$42.50 15.2%134.071 of 5 stars3.74%ONCBeOne Medicines$351.48+0.7%Buy$404.93 15.2%173.9328 of 5 stars3.63%ADMAADMA Biologics$10.34+0.3%Moderate Buy$18.67 80.5%63.9085 of 5 stars3.62%RGENRepligen$178.20+1.6%Moderate Buy$173.21 -2.8%182.2086 of 5 stars3.62%NEONeoGenomics$16.88+1.3%Moderate Buy$18.17 7.6%101.9894 of 5 starsAnalyst Forecast3.61%GILDGilead Sciences$153.54+3.8%Moderate Buy$159.33 3.8%293.2204 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.58%AMGNAmgen$426.11+3.2%Hold$387.93 -9.0%303.7651 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.55%REGNRegeneron Pharmaceuticals$778.36+3.4%Moderate Buy$834.24 7.2%314.521 of 5 starsPositive News3.50%BIIBBiogen$232.83+1.7%Moderate Buy$236.04 1.4%322.5273 of 5 starsAnalyst Upgrade3.33%EXELExelixis$60.99+2.5%Hold$50.79 -16.7%202.3041 of 5 starsAnalyst Revision3.31%VRTXVertex Pharmaceuticals$498.50+2.7%Moderate Buy$579.81 16.3%284.0868 of 5 stars3.24%TECHBio-Techne$72.50+0.0%Hold$68.92 -4.9%172.6565 of 5 stars3.21%BNTXBioNTech$88.66-0.4%Moderate Buy$125.44 41.5%203.8308 of 5 starsTrending NewsAnalyst Forecast3.11%UTHRUnited Therapeutics$540.03-0.6%Moderate Buy$639.08 18.3%144.0897 of 5 starsTrending NewsAnalyst ForecastInsider Trade3.08%BRKRBruker$55.60-1.1%Moderate Buy$59.43 6.9%143.6685 of 5 starsAnalyst Forecast3.08%INCYIncyte$111.57+2.7%Moderate Buy$128.20 14.9%253.9192 of 5 starsAnalyst Forecast3.07%SRPTSarepta Therapeutics$16.83+1.9%Reduce$22.59 34.2%213.3498 of 5 starsAnalyst Upgrade2.98%TGTXTG Therapeutics$54.37+0.1%Moderate Buy$63.00 15.9%93.5159 of 5 stars2.98%ARGXargenex$818.30+2.0%Moderate Buy$1,151.95 40.8%304.7053 of 5 starsAnalyst Forecast2.96%BMRNBioMarin Pharmaceutical$55.14+1.4%Moderate Buy$88.87 61.2%244.4805 of 5 starsAnalyst Upgrade2.83%MDGLMadrigal Pharmaceuticals$460.01+1.7%Moderate Buy$699.20 52.0%182.9642 of 5 starsAnalyst Forecast This page (NYSEARCA:FBT) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredMy next big call (under $1)The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a...Crypto 101 Media | SponsoredElon pays this company. Every time.Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBT Stock Alerts